3.4. Programmed Death Ligand 1(PDL1) and Tyrosine Protein Kinase (MET) Expression on CTCs from Non-Small Cell Lung Cancer (NSCLC) Patients. The gene discussed is MET; the disease is non-small cell lung carcinoma.